BNP Paribas Asset Management
PRCT icon

BNP Paribas Asset Management’s Procept Biorobotics PRCT Stock Holding History

BNP Paribas Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.3M Sell
3,089,378
-5,271
-0.2% -$149K 0.09% 230
2025
Q4 		$97.4M Buy
3,094,649
+2,002,389
+183% +$66.4M 0.11% 180
2025
Q3 		$39M Buy
1,092,260
+308,047
+39% +$14.1M 0.1% 216
2025
Q2 		$45.2M Buy
784,213
+440,702
+128% +$24.9M 0.11% 192
2025
Q1 		$20M Sell
343,511
-151,206
-31% -$10.3M 0.05% 345
2024
Q4 		$39.8M Sell
494,717
-15,936
-3% -$1.36M 0.1% 217
2024
Q3 		$40.9M Sell
510,653
-9,297
-2% -$660K 0.1% 206
2024
Q2 		$31.8M Sell
519,950
-107,872
-17% -$6.42M 0.08% 240
2024
Q1 		$31M Buy
627,822
+51,305
+9% +$2.44M 0.08% 248
2023
Q4 		$24.2M Buy
576,517
+17,492
+3% +$596K 0.07% 272
2023
Q3 		$18.3M Buy
559,025
+335,472
+150% +$11.4M 0.06% 305
2023
Q2 		$7.9M Buy
+223,553
New +$7.39M 0.02% 442

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Asset Management's PRCT Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Procept Biorobotics (PRCT) stake by 0.17% in Q1 2026, selling an estimated $149K and leaving 3,089,378 shares worth $77.3M. The position accounts for 0.09% of the portfolio, ranked #230.

BNP Paribas Asset Management first reported a position in PRCT in Q2 2023 and has held it in 12 quarters since. The position peaked at $97.4M in Q4 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • BNP Paribas Asset Management held 3,089,378 shares of Procept Biorobotics worth $77.3M as of Q1 2026.
  • BNP Paribas Asset Management sold 5,271 Procept Biorobotics shares in Q1 2026, an estimated $149K.
  • Procept Biorobotics made up 0.09% of BNP Paribas Asset Management's portfolio in Q1 2026, its #230 holding.
  • BNP Paribas Asset Management first reported a position in Procept Biorobotics in Q2 2023 and has held it in 12 quarters since.
  • BNP Paribas Asset Management's Procept Biorobotics position peaked at $97.4M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.